LONDON--(BUSINESS WIRE)--The single-photon emission computed tomography (SPECT) market is poised to grow by USD 620.21 million during 2020-2024, progressing at a CAGR of over 6% during the forecast ...
Patients who receive cardiac positron emission testing (PET) imaging instead of single photon emission computed tomography (SPECT) scan experienced a significant increase in the detection of severe ...
Left: primary/scatter window SPECT reconstructions, plus synthetic and CT-based attenuation maps. Right: SPECT reconstructed images corrected using CT-based attenuation maps, synthetic attenuation ...
Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians Find, Fight, and Follow disease to deliver better ...
To lead the integration and growth of the SPECT business, SHINE has named Michael Rossi as CEO of SHINE SPECT USA, LLC.
Functional (PET/CT) compared to conventional (mammography [M], sonography [US], MRI) imaging: Defining novel assessment modalities for inflammatory breast cancer (IBC) No significant financial ...
June 24, 2003 (New Orleans) — Studies using positron emission tomography (PET) and other approaches suggest new details about the underlying biology of attention deficit-hyperactivity disorder (ADHD).
Patients who receive cardiac positron emission testing (PET) imaging instead of single photon emission computed tomography (SPECT) scan experienced a significant increase in the detection of severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback